関連する実験動画
Updated: Jul 12, 2026

08:05
Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
TAK1は,MKKとIKKのユビキチン依存キナーゼである
1Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9148, USA.
Nature
|July 19, 2001
まとめ
腫瘍死滅因子受容体関連因子6 (TRAF6) は,主要な炎症性キナーゼを活性化します. この研究では,TRIKA1複合体であるTRIKA2を特定し,ユビキチネーションを明らかにしました.
科学分野:
- * 分子・細胞生物学
- * 免疫学について
- * シグナルトランスデュークション
背景:
- *Tumor necrosis factor receptor-associated factor 6 (TRAF6) は,インタールイキン-1 (IL-1) やリポポリサッカリド (LPS) などの炎症促進媒介体の重要な信号トランスデューサーである.
- * TRAF6は,細胞のストレス反応に不可欠なイカッパBキナーゼ (IKK) とジュンアミノ端末キナーゼ (JNK) 経路を活性化します.
- *以前は,TRIKA1とTRIKA2の中間因子を含むTRAF6媒介のIKK活性化が示唆されていたが,TRIKA2の組成とメカニズムは不明のままだった.
研究 の 目的:
- *TRIKA2の成分を浄化し,特定する.TRIKA2は,TRAF6媒介のシグナル伝達における重要な中間体である.
- *TRIKA2がIKKとJNK経路の活性化に寄与するメカニズムを解明する.
- *これらの重要なストレス反応経路の調節におけるユビキチネーションの役割を調査する.
主な方法:
- * TRIKA2.2を分離し特徴づけるために,タンパク質浄化と複雑な識別技術が採用されました.
- * IKKとMK6.6におけるTAK1複合体のリン酸化活性を評価するために,インビトロキナーゼアッセイを実施した.
- *ポリユビキチネーションアッセイは,Lys 63 (K63) に結合したポリユビキチン鎖をTRAF6で検出および分析し,経路活性化への影響を分析するために使用されました.
主要な成果:
- *TRIKA2は,TAK1,TAB1およびTAB2を含む複合体として特定されました.
- * TRAF6とUbc13-Uev1Aに依存するTAK1キナーゼ複合体は,IKKをリン酸化して活性化します.
- * Lys 63 (K63) 関連ポリユビキチネーションは,MKK6に対するTAK1の活性を直接調節することが示され,TRAF6.6と結合していることが判明しました.
結論:
- *ウビキチネーション,特にK63関連ポリウビキチネーションは,炎症およびストレス反応のシグナル伝達経路において重要な規制的役割を果たします.
- * TRIKA2をTAK1複合体として特定することで,TRAF6媒介のユビキチネーションとIKKとJNK経路の活性化との間のメカニズム的な関連が示されている.
- * この研究は,K63結合ポリユビキチン鎖によって介されるIKK活性化のための独特な,プロテアソーム独立メカニズムを明らかにし,細胞シグナル伝達におけるユビキチネーションの重要性を強調しています.
関連する概念動画
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...

